Domestic Animal Endocrinology
Volume 24, Issue 1 , Pages 59-68 , January 2003

Pulsatile secretion pattern of growth hormone in dogs with pituitary-dependent hyperadrenocorticism

  • W.M Lee

      Affiliations

    • Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, P. O. Box 80, 154, NL-3508 TD Utrecht, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31-30-2539411; fax: +31-30-2518126.
    • ,
  • B.P Meij

      Affiliations

    • Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, P. O. Box 80, 154, NL-3508 TD Utrecht, The Netherlands
    • ,
  • S.F.M Bhatti

      Affiliations

    • Department of Small Animal Medicine and Clinical Biology, Ghent University, Salisburylaan 133, B-9820 Merelbeke, Belgium
    • ,
  • J.A Mol

      Affiliations

    • Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, P. O. Box 80, 154, NL-3508 TD Utrecht, The Netherlands
    • ,
  • A Rijnberk

      Affiliations

    • Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, P. O. Box 80, 154, NL-3508 TD Utrecht, The Netherlands
    • ,
  • H.S Kooistra

      Affiliations

    • Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, P. O. Box 80, 154, NL-3508 TD Utrecht, The Netherlands

Received 16 April 2002 ,Accepted 22 July 2002.

References 

  1. Takahashi Y, Ebihara S, Nakamura Y, Takahashi K. A model of human sleep-related growth hormone secretion in dogs: effects of 3,6, and 12 hours of forced wakefulness on plasma growth hormone, cortisol, and sleep stages. Endocrinology. 1981;109:262–272
  2. Kooistra HS, Den Hertog E, Okkens AC, Mol JA, Rijnberk A. Pulsatile secretion pattern of growth hormone during the luteal phase and mid-anoestrus in beagle bitches. J. Reprod. Fertil. 2000;119:217–222
  3. Lee WM, Diaz-Espineira M, Mol JA, Rijnberk A, Kooistra HS. Primary hypothyroidism in dogs is associated with elevated GH release. J. Endocrinol. 2001;168:59–66
  4. Plotsky PM, Vale W. Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. Science. 1985;230:461–463
  5. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656–660
  6. Devesa J, Lima L, Tresguerres JAF. Neuroendocrine control of growth hormone secretion in humans. Trends Endocrinol. Metab. 1992;3:175–183
  7. Evans RM, Birnberg NC, Rosenfeld MG. Glucocorticoid and thyroid hormones transcriptionally regulate growth hormone gene expression. Proc. Natl. Acad. Sci. U.S.A. 1982;79:7659–7663
  8. Karin M, Castrillo JL, Theill LE. Growth hormone gene regulation: a paradigm for cell-type-specific gene activation. Trends Genet. 1990;6:92–96
  9. Seifert H, Perrin M, Rivier J, Vale W. Growth hormone-releasing factor binding sites in rat anterior pituitary membrane homogenates: glucocorticoid. Endocrinology. 1985;117:424–426
  10. Miller L, Mayo KE. Glucocorticoids regulate pituitary growth hormone-releasing hormone receptor messenger ribonucleic acid expression. Endocrinology. 1997;138:2458–2465
  11. Ohyama T, Sato M, Ohye H, Murao K, Niimi M, Takahara J. Effects of adrenalectomy and glucocorticoid receptor antagonist, RU38486, on pituitary growth hormone-releasing hormone receptor gene expression in rats. Peptides. 1998;19:1063–1067
  12. Wehrenberg WB, Baird A, Ling N. Potent interaction between glucocorticoids and growth hormone-releasing factor in vivo. Science. 1983;221:556–558
  13. Casanueva FF, Burguera B, Muruais C, Dieguez C. Acute administration of corticoids: a new and peculiar stimulus of growth hormone secretion in man. J. Clin. Endocrinol. Metab. 1990;70:234–237
  14. Veldhuis JD, Lizarralde G, Iranmanesh A. Divergent effects of short term glucocorticoid excess on the gonadotropic and somatotropic axes in normal men. J. Clin. Endocrinol. Metab. 1992;74:96–102
  15. Allen DB. Growth suppression by glucocorticoid therapy. Endocrinol. Metab. Clin. North Am. 1996;25:699–717
  16. Giustina A, Romanelli G, Bossoni S, Girelli A, Pizzocolo G, Valentini U, et al.  Effects of short-term glucocorticoid deprivation on growth hormone (GH) response to GH-releasing hormone in man. Horm. Metab. Res. 1989;21:693–694
  17. Takahashi H, Bando H, Zhang C, Yamasaki R, Saito S. Mechanism of impaired growth hormone secretion in patients with Cushing’s disease. Acta Endocrinol. 1992;127:13–17
  18. Magiakou MA, Mastorakos G, Gomez MT, Rose SR, Chrousos GP. Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing’s disease before and after surgical cure. J. Clin. Endocrinol. Metab. 1994;78:131–137
  19. Borges MH, DiNinno FB, Lengyel AM. Different effects of growth hormone releasing peptide (GHRP-6) and GH-releasing hormone on GH release in endogenous and exogenous hypercortisolism. Clin. Endocrinol. 1997;46:713–718
  20. Kemppainen RJ, Peterson ME. Animal models of Cushing’s disease. Trends Endocrinol. Metab. 1994;5:21–28
  21. Peterson ME, Altszuler N. Suppression of growth hormone secretion in spontaneous canine hyperadrenocorticism and its reversal after treatment. Am. J. Vet. Res. 1981;42:1881–1883
  22. Regnier A, Garnier F. Growth hormone responses to growth hormone-releasing hormone and clonidine in dogs with Cushing’s syndrome. Res. Vet. Sci. 1995;58:169–173
  23. Meij BP, Mol JA, Bevers MM, Rijnberk A. Alterations in anterior pituitary function of dogs with pituitary-dependent hyperadrenocorticism. J. Endocrinol. 1997;154:505–512
  24. Rijnberk A, Van Wees A, Mol JA. Assessment of two tests for the diagnosis of canine hyperadrenocorticism. Vet. Rec. 1988;122:178–180
  25. Voorhout G, Rijnberk A, Sjollema BE, Van de Ingh TSGAM. Nephrotomography and ultrasonography for the localization of hyperfunctioning adrenocortical tumors in dogs. Am. J. Vet. Res. 1990;51:1280–1285
  26. Kooistra HS, Voorhout G, Mol JA, Rijnberk A. Correlation between impairment of glucocorticoid feedback and the size of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. J. Endocrinol. 1997;152:387–394
  27. Meij BP, Voorhout G, Van Den Ingh TSGAM, Hazewinkel HAW, Teske E, Rijnberk A. Results of transsphenoidal hypophysectomy in 52 dogs with pituitary-dependent hyperadrenocorticism. Vet. Surg. 1998;27:246–261
  28. Findling JW, England WC. A new immunoradiometric assay for the measurement of corticotropin in human plasma. Trends Endocrinol. Metab. 1990;6:678
  29. Stolp R, Rijnberk A, Meijer JC, Croughs RJ. Urinary corticoids in the diagnosis of canine hyperadrenocorticism. Res. Vet. Sci. 1983;34:141–144
  30. Eigenmann JE, Eigenmann RY. Radioimmunoassay of canine growth hormone. Acta Endocrinol. 1981;98:628–634
  31. Merriam GR, Wachter KW. Algorithms for the study of episodic hormone secretion. Am. J. Physiol. 1982;243:310–318
  32. Wajchenberg BL, Liberman B, Gianella Neto D, Morozimato MY, Semer M, Bracco LO, et al.  Growth hormone axis in Cushing’s syndrome. Horm. Res. 1996;45:99–107
  33. Ohyama T, Sato M, Niimi M, Hizuka N, Takahara J. Effects of short- and long-term dexamethasone treatment on growth and growth hormone (GH)-releasing hormone (GRH)-insulin-like growth factor-1 axis in conscious rats. Endocrine. 1997;44:827–835
  34. Wehrenberg WB, Bergman PJ, Stagg L, Ndon J, Giustina A. Glucocorticoid inhibition of growth in rats: partial reversal with somatostatin antibodies. Endocrinology. 1990;127:2705–2708
  35. Lima L, Arce V, Diaz MJ, Tresguerres JA, Devesa J. Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons. J. Clin. Endocrinol. Metab. 1993;76:439–444
  36. Terzolo M, Bossoni S, Ali A, Doga M, Reimonda G, Milani G, et al.  Growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone. J. Clin. Endocriol. Metab. 2000;85:1310–1315
  37. Nakagawa K, Ishizuka T, Obara T, Matsubara M, Akikawa K. Dichotomic action of glucocorticoids on growth hormone secretion. Acta Endocrinol. 1987;116:165–171
  38. Nakagawa K, Ishizuka T, Shimizu C, Ito Y, Wakabayashi I. Increased hypothalamic somatostatin mRNA following dexamethasone administration in rats. Acta Endocrinol. 1992;127:416–419
  39. Mallo F, Alvarez CV, Benitez L, Burguera B, Coya R, Casanueva FF, et al.  Regulation of His-dTrp-Ala-Trp-dPhe-Lys-NH2 (GHRP-6)-induced GH secretion in the rat. Neuroendocrinology. 1993;57:247–256
  40. Leal-Cerro A, Pereira JL, Garcia-Luna PP, Astorga R, Cordido F, Casanueva FF, et al.  Effect of enhancement of endogenous cholinergic tone with pyridostigmine on growth hormone (GH) responses to GH-releasing hormone in patients with Cushing’s syndrome. Clin. Endocrinol. 1990;33:291–295
  41. Miell J, Corder R, Miell PJ, McClean C, Gaillard RC. Effects of glucocorticoid treatment and acute passive immunization with growth hormone-releasing hormone and somatostatin antibodies on endogenous and stimulated growth hormone secretion in the male rat. J. Endocrinol. 1991;131:75–86
  42. Senaris RM, Lago F, Coya R, Pineda J, Dieguez C. Regulation of hypothalamic somatostatin, growth hormone-releasing hormone, and growth hormone receptor messenger ribonucleic acid by glucocorticoids. Endocrinology. 1996;137:5236–5241
  43. Hotta M, Shibasaki T, Masuda A, Imaki T, Sugino N, Demura H, et al.  Effect of human growth hormone-releasing hormone on GH secretion in Cushing’s syndrome and non-endocrine disease patients treated with glucocorticoids. Life Sci. 1988;42:979–984
  44. Burguera B, Muruais C, Penalva A, Dieguez C, Casanueva FF. Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man. Neuroendocrinology. 1990;51:51–58
  45. Voltz DM, Piering AW, Magestro M, Giustina A, Wehrenberg WB. Effect of GHRP-6 and GHRH on GH secretion in rats following chronic glucocorticoid treatment. Life Sci. 1995;56:491–497
  46. Watson S, Porter RJ, Young AH. Effect of hydrocortisone on the pituitary response to growth hormone releasing hormone. Psychopharmacology. 2000;152:40–46
  47. Leal-Cerro A, Pumar A, Garcia-Garcia E, Dieguez C, Casanueva FF. Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing’s syndrome. Clin. Endocrinol. 1994;41:649–654
  48. Miki N, Ono M, Murata Y, Ohsaki E, Tamitsu K, Yamada M, et al.  Regulation of pituitary growth hormone-releasing factor (GRF) receptor gene expression by GRF. Biochem. Biophys. Res. Commun. 1996;224:586–590
  49. Thakore JH, Dinan TG. Growth hormone secretion: the role of glucocorticoids. Life Sci. 1994;55:1083–1099
  50. Leal-Cerro A, Pumar A, Villamil F, Astorga R, Dieguez C, Casanueva FF. Growth hormone releasing hormone priming increases growth hormone secretion in patients with Cushing’s syndrome. Clin. Endocrinol. 1993;38:399–403
  51. Niimi K, Krieg RJ, Hanna JD, Santos F, Chan JC. Glucocorticoid-induced changes in the quantity and secretory capacity of individual rat somatotropes. J. Am. Soc. Nephrol. 1993;3:1428–1433
  52. Rijnberk A. Hypothalamus-pituitary system. Clinical endocrinology of dogs and cats. Kluwer Academic Publishers: Dordrecht, The Netherlands; 1996.
  53. Cordido F, Penalva A, Dieguez C, Casanueva FF. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. J. Clin. Endocrinol. Metab. 1993;76:819–823
  54. Leal-Cerro A, Jimenez LM, Astorga R, Fernandez-Lopez I, Dieguez C, Casanueva FF. Acute pharmacological reduction of plasma free fatty acids enhances the growth hormone (GH)-releasing hormone-mediated GH secretion in patients with Cushing’s syndrome. J. Clin. Endocrinol. Metab. 1997;82:3165–3168
  55. Pombo M, Pombo CM, Astorga R, Cordido F, Popovic V, Garcia-Mayor RV, et al.  Regulation of growth hormone secretion by signals produced by the adipose tissue. J. Endocrinol. Invest. 1999;22:22–26
  56. Leal-Cerro A, Venegas E, Garcia-Pesquera F, Jimenez LM, Astorga R, Casanueva FF, et al.  Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary restriction in patients with Cushing’s syndrome. Clin. Endocrinol. 1998;48:117–121
  57. Finkelstein JW, Roffwarg HP, Bouar RM, Kream HJ, Hellman L. Age-related change in the twenty-four-hour spontaneous secretion of growth hormone. J. Clin. Endocrinol. Metab. 1972;35:665–670
  58. Zadik Z, Chalew SA, McCarter RJ, Meistas M, Kowarski AA. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J. Clin. Endocrinol. Metab. 1985;60:513–516
  59. Wilshire GB, Loughlin JS, Brown JR, Adel TE, Santoro N. Diminished function of the somatotropic axis in older reproductive-aged women. J. Clin. Endocrinol. Metab. 1995;80:608–613
  60. Sonntag WE, Steger RW, Forman LJ, Meites J. Decreased pulsatile release of growth hormone in old male rats. Endocrinology. 1980;107:1875–1879
  61. De Gennaro Colonna V, Cella SG, Parenti M, Locatelli V, Cocchi D, Muller EE. Neuroendocrine aging: its impact on somatotrophic function. Neurochem. Int. 1994;25:5–10
  62. Shetty KP, Duthie EH. Anterior pituitary function and growth hormone use in the elderly. Endocrinol. Metab. Clin. North Am. 1995;24:213–231
  63. Veldhuis JD. Altered pulsatile and coordinate secretion of pituitary hormones in aging: evidence of feedback disruption. Aging. 1997;9(Suppl 4):19–20
  64. Takahashi S, Kawashima S, Seo H, Matsui N. Age-related changes in growth hormone and prolactin messenger RNA levels in the rat. Endocrinol. Jpn. 1990;37:827–840

PII: S0739-7240(02)00205-9

Domestic Animal Endocrinology
Volume 24, Issue 1 , Pages 59-68 , January 2003

Article Tools

* Image Usage & Resolution